Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Sepsis-Induced Acute Lung Injury
NCT00979121Phase 3Terminated
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jan 2010
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in acute lung injury (ALI), sponsored by National Heart, Lung, and Blood Institute. Started Jan 2010; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NCT00979121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979121.